TORONTO, Nov. 3, 2014 /CNW/ - Valeant Canada welcomes and encourages members of the media to contact the company for accurate and clinically proven information regarding COLD-FX.
Dr. Jeff Habert, Family Physician in Thornhill, Ontario and lecturer in the Department of Family and Community Medicine at the University of Toronto is available to qualify the use and efficacy of COLD-FX. "Clinical studies suggest when used in a preventative manner, COLD-FX helps reduce the frequency, severity and duration of cold and flu symptoms," said Dr. Habert.
COLD-FX is a researched, "ChemBioPrint" standardized ingredient and validated product that is clinically proven to boost your immune system. Each capsule contains CVT-E002 – extracted using a patented process to enrich immunomodulating active ingredients. COLD-FX is a natural health product that helps reduce the frequency, duration and severity of cold & flu symptoms by boosting the immune system.
COLD-FX is produced by Valeant Pharmaceuticals International, Inc. (NYSE/TSX:VRX), a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, eye health, neurology and branded generics. More information about COLD-FX can be found at www.cold-fx.ca. More information about Valeant can be found at www.valeant.com.
For further information: Caroline De Silva, Argyle Communications, 416-968-7311 ext. 231, firstname.lastname@example.org; Sébastien Beauchamp, Valeant Canada LP, 514-744-6792, email@example.com